Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.77 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | MAN2A1 | Q16706 | 1/20 | 0.33 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.33 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13038632 | 0.89 | CYP2D6 (0.77) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| SCHEMBL30860164 | 0.89 | CYP2D6 (0.77) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| SCHEMBL31377127 | 0.88 | CYP2D6 (0.75) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| SCHEMBL31454028 | 0.88 | CYP2D6 (0.75) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| SCHEMBL31377367 | 0.88 | CYP2D6 (0.75) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| SCHEMBL29351359 | 0.88 | CYP2D6 (0.74) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| Anisomycin SCHEMBL18059879 | 0.87 | SMN1; SMN2 (1.00) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| Anisomycin SCHEMBL8331774 | 0.87 | SMN1; SMN2 (1.00) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| Anisomycin SCHEMBL898674 | 0.87 | SMN1; SMN2 (1.00) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A | |
| Anisomycin SCHEMBL2270187 | 0.87 | SMN1; SMN2 (1.00) | CYP2D6SMN1; SMN2LMNAMAPK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773109-B2 | Composition for hardening soft tissue | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION | 2023-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773109-B2 | Composition for hardening soft tissue | PNLIP, AMY2A, RNASE1 | CYP2D6 4796/4885SMN1; SMN2 409/4885LMNA 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.